Table 5: Subgroups for Tdap and zoster vaccines.
|
|
Tdap |
Zoster |
||
|
Subgroups |
Baseline |
Follow-up |
Baseline |
Follow-up |
|
Age (years) |
|
|
|
|
|
< 65 years |
54,980/109,731 (50.1%) |
67,781/108,372 (62.5%) |
4,575/14,558 (31.4%) |
6,517/17,167 (38.0%) |
|
65 - 80 years |
16,530/36,109 (45.8%) |
18,410/34,172 (53.9%) |
10,453/35,295 (29.6%) |
12,208/32,918 (37.1%) |
|
> 80 years |
2,522/8,049 (31.3%) |
2,553/6,600 (38.7%) |
1,463/7,863 (18.6%) |
1,569/6,320 (24.8%) |
|
Sex |
|
|
|
|
|
Female |
43,967/92,599 (47.5%) |
53,759/90,502 (59.4%) |
9,612/34,496 (27.9%) |
11,985/33,784 (35.5%) |
|
Male |
30,065/61,290 (49.1%) |
34,985/58,642 (59.7%) |
6,879/23,220 (29.6%) |
8,309/22,621 (36.7%) |
|
Race |
|
|
|
|
|
White |
48,665/100,769 (48.3%) |
57,659/97,249 (59.3%) |
13,315/41,993 (31.7%) |
16,207/40,826 (39.7%) |
|
Black or African American |
18,283/38,046 (48.1%) |
22,756/37,955 (60.0%) |
2,345/12,440 (18.9%) |
3,103/12,514 (24.8%) |
|
Asian/Pacific Islander |
2,761/5,207 (53.0%) |
3,783/5,970 (63.4%) |
336/1,156 (29.1%) |
456/1,277 (35.7%) |
|
Other, reported |
2,588/5,704 (45.4%) |
2,529/4,322 (58.5%) |
261/1,139 (22.9%) |
240/894 (26.8%) |
|
Insurance |
|
|
|
|
|
Government |
17,816/41,755 (42.7%) |
23,005/43,722 (52.6%) |
8,989/33,121 (27.1%) |
11,848/34,292 (34.6%) |
|
Private |
49,307/95,817 (51.5%) |
56,587/88,595 (63.9%) |
5,100/14,677 (34.7%) |
5,665/13,515 (41.9%) |
|
Multiple |
6,007/13,343 (45.0%) |
7,816/13,901 (56.2%) |
2,378/9,536 (24.9%) |
2,745/8,237 (33.3%) |
|
None |
902/2,974 (30.3%) |
1,336/2,926 (45.7%) |
24/382 (6.3%) |
36/361 (10.0%) |
|
Cancer history |
|
|
|
|
|
Yes |
9,020/18,566 (48.6%) |
10,644/18,394 (57.9%) |
3,975/13,037 (30.5%) |
4,960/12,477 (39.8%) |
|
No |
65,012/135,323 (48.0%) |
78,100/130,750 (59.7%) |
12,516/44,679 (28.0%) |
15,334/43,928 (34.9%) |
|
Diabetes |
|
|
|
|
|
Yes |
11,411/23,666 (48.2%) |
13,288/22,694 (58.6%) |
3,474/13,951 (24.9%) |
4,269/13,263 (32.2%) |
|
No |
62,621/130,223 (48.1%) |
75,456/126,450 (59.7%) |
13,017/43,765 (29.7%) |
16,025/43,142 (37.1%) |
|
Chronic lung disease |
|
|
|
|
|
Yes |
5,325/10,608 (50.2%) |
6,759/11,336 (59.6%) |
1,456/5,728 (25.4%) |
1,929/5,885 (32.8%) |
|
No |
68,707/143,281 (48.0%) |
81,985/137,808 (59.5%) |
15,035/51,988 (28.9%) |
18,365/50,520 (36.4%) |